Dexa Group was awarded The Best Indonesia Public Relations Award in the Pharmaceutical Category by the Indonesia Corporate Public Relations Award (IPRA) 2022 for its performance in Corporate Public Relations. Dexa Group has won the IPRA Award for the fourth time since 2018.
With the theme “Creating Impact for a Better Future,” IPRA 2022 is being held to give the highest award to public relations companies, with excellent roles and functions to improve the quality of companies during increasingly fierce industrial competition and improving Indonesian economic conditions.
On Thursday, January 27, 2022, the award was virtually presented by Mr. Edy Nurmansyah, Business Director of Warta Ekonomi, and virtual accompanied by Mr. Muhammad Ihsan, CEO of Warta Ekonomi, and Prof. Dr. Ir. H. Fadel Muhammad, Founder of Warta Ekonomi. The award was received by the Director of Corporate Affairs of Dexa Group, Mr. Krestijanto Pandji.
Mr. Krestijanto expressed his gratitude for the recognition granted by Warta Ekonomi in his acceptance speech. “Receiving this award is a great honour for us, and it’s essential for us because it is critical in the pharmaceutical industry to deliver accurate information to the public, especially in this pandemic era when there is a lot of conflicting information. As a result, through public relations, we can assist in providing more precise, more accurate information, ensuring that there are no miscommunications in Indonesian society “, Mr. Krestijanto stated.
Mr. Krestijanto went on to say that Dexa Group is devoted to growing its brand both in Indonesia and overseas. Dexa Group also hopes to do more significant exports in the future, particularly regarding Indonesian Indigenous Modern Medicines (OMAI) and monitor OMAI’s introduction into the National Health Insurance.
The award was given to 17 industrial sectors in Indonesia, determined by desk research on the company’s performance in 2021 and a media monitoring study on Indonesian mainstream media and social media. The Monitoring was executed in 2021 for the news with a positive sentiment.